ARTICLE | Clinical News
Xarano ethacrynate sodium to prevent increased intraocular pressure: Completed patient enrollment in a Phase III trial, which should be completed in the second
June 12, 1995 7:00 AM UTC
Telor Ophthalmic Pharmaceuticals Inc. (TELR), Wilmington, Mass. Product: Xarano ethacrynate sodium to prevent increased intraocular pressure Indication: Cataract surgery Status: Completed patient enro...